Global Finance Herald: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Finance Herald.

Press releases published on June 22, 2026

Jun. 22, 2026

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

Jun. 22, 2026

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

Indeterminate GlobeNewswire

Jun. 22, 2026

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

Jun. 22, 2026

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Indeterminate GlobeNewswire

Jun. 22, 2026

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Indeterminate GlobeNewswire

Jun. 22, 2026

CaoCao Announces Full-Scale AI Transformation, Unveils RoboX Strategy to Build a Globally Leading Physical AI Mobility Technology Platform

Indeterminate GlobeNewswire

Jun. 22, 2026

Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million

Indeterminate GlobeNewswire

Jun. 22, 2026

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Indeterminate GlobeNewswire

Jun. 22, 2026

GRAL INVESTOR NOTICE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

Indeterminate GlobeNewswire

Jun. 22, 2026

Resolution Minerals joins U.S. Defense Industrial Base Consortium to advance critical minerals strategy

Indeterminate EIN Presswire

Jun. 22, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

Jun. 22, 2026

Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 22, 2026

Xeriant Sets Up Next Production Run of NEXBOARD™ Following Class A Fire Rating and NFPA 286 Fire Testing Certification

Indeterminate GlobeNewswire

Jun. 22, 2026

Firm Capital Property Trust Announces Completion of Competition Bureau of Canada Inquiry Regarding Acquisition of 50% Interests in Ten Manufactured Home Communities for $218 Million

Indeterminate GlobeNewswire

Jun. 22, 2026

Vape-Jet Establishes New Headquarters in Pittsburgh’s Renowned Robotics Row

Indeterminate EIN Presswire

Jun. 22, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Jun. 22, 2026

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Indeterminate GlobeNewswire

Jun. 22, 2026

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire

Jun. 22, 2026

Capstone Asset Management Inc. announces second quarter 2026 cash distributions for ETF Series of Capstone Funds

Indeterminate GlobeNewswire

Jun. 22, 2026

Lifetime Brands, Inc. Announces Results of 2026 Annual Meeting

Indeterminate GlobeNewswire